Company Dynamics

Degas Group passed the 2022 Shandong Province "Specialized and Special New" Enterprise Recognition

On June 16, the Shandong Provincial Department of Industry and Information Technology released the "Announcement on the List of" Specialized, Special and New "Small and Medium-sized Enterprises in Shandong Province in 2022". With its product research and development and innovation advantages in the field of pharmaceutical raw materials and pharmaceutical intermediates, Dijia Pharmaceutical Group was selected into the list of "Specialized, Special and New" enterprises in Shandong Province in 2022. Prior to this, Degas Group successfully passed the recognition of Weihai's "specialized and special new" enterprise in May.
"Specialization and innovation" is a major project implemented by the state to promote the development of specialization, refinement, characteristics and innovation of small and medium-sized enterprises, enhance independent innovation and core competitiveness, and improve the quality and level of development of small and medium-sized enterprises. The enterprises cultivated, selected and supported are usually industry leaders who focus on market segmentation, focus on key technologies, have strong innovation ability, good growth, high market share and excellent quality and efficiency, and play an indispensable role in promoting economic development and realizing independent innovation in professional fields.
DIGA Group insists on innovation as the driving force for development. Since its establishment for nearly ten years, it has continuously explored the technological innovation and application of pharmaceutical raw materials and intermediates. At present, it has a scientific research site with an area of more than 6000 square meters. It has built Shandong Analgesic Drug Engineering Technology Research Center, Shandong One Enterprise One Technology Center and Shandong Enterprise Technology Center. It has successively undertaken 2 National Torch Plan projects, national industrial revitalization and technological transformation One item, 1 major project for the transformation of independent innovation achievements in Shandong Province, 116 technological innovation projects in Shandong Province, 74 authorized invention patents, 4 new drug certificates, won 1 second prize of National Science and Technology Progress Award, 3 first prizes of Shandong Science and Technology Progress Award, and 3 second prizes of Shandong Science and Technology Progress Award. Has passed the European Union CEP, South Korea MFDS, Japan PMDA, India CDSCO and other international registration and certification.
The selection of "specialized and special new" enterprises is the affirmation of the competent departments, professional institutions and industries to the technological innovation, product quality, environmental protection and safety, service and growth ability of Dijia Group over the years. With the continuous development of domestic pharmaceutical innovation and the strategic promotion of the national pharmaceutical and health industry, Dijia Group will continue to cultivate the industry, focus on the field of pharmaceutical raw materials, constantly improve the management system and mechanism and the training of domestic first-class pharmaceutical R & D personnel, to ensure the company's continuous innovation ability and rapid development.